(Q38990425)

8 September 2017

title

Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4. (English)

1 reference

8 September 2017

1 reference

1 reference

el-Zayadi A

1

1 reference

8 September 2017

Simmonds P

2

1 reference

8 September 2017

Dabbous H

3

1 reference

8 September 2017

Prescott L

4

1 reference

8 September 2017

Selim O

5

1 reference

8 September 2017

Ahdy A

6

1 reference

8 September 2017

publication date

1 September 1996

1 reference

Journal of Viral Hepatitis

8 September 2017

published in

1 reference

8 September 2017

volume

3

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

261-264

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Hepatitis C serotype and response to interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Hepatitis C virus genotypes in chronic hepatitis and response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response,

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00052.X

10.1111/J.1365-2893.1996.TB00052.X

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference